findmyKOL
Clinical trialNCT04344587CompletedInterventional

Awake Prone Position for Early Hypoxemia in COVID-19

SponsorBoston UniversityEnrollment305COVID-19
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Prone positioning is a well studied and validated treatment for severe acute respiratory distress syndrome (ARDS), however there are no randomized studies on the use of prone positioning in the non-intubated patient. It is unknown if this intervention would be helpful in preventing further respiratory deterioration in terms of increasing supplemental oxygen requirements, endotracheal intubation, and ICU admission. The Awake Prone Position for Early hypoxemia in COVID-19 (APPEX-19) Study is a pragmatic adaptive randomized controlled unblinded trial. APPEX-19 randomizes non-ICU patients with COVID-19 or who are under evaluation for COVID-19 to lie in a prone position (i.e, with their stomach and chest facing down) or to usual care.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital Universitario la Paz

    Madrid, Spain

United States
  • Long Beach Medical Center - Memorialcare

    Long Beach, California, United States

  • Alvarado Hospital

    San Diego, California, United States

  • St. Joseph'S Hospital National Jewish Health

    Denver, Colorado, United States

  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • Piedmont Atlanta

    Atlanta, Georgia, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Creighton University

    Omaha, Nebraska, United States

  • Michael E. Debakey Veteran Affairs Medical Center

    Houston, Texas, United States

  • Vcu Medical Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Apr 2020
Primary completion
7 May 2021
Completion
7 May 2021
Last update posted
1 Nov 2021
Registered enrollment
305
Registry id
NCT04344587

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.